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Abstract
Background: To evaluate the influence of combined therapy of conventional and herbal medicines on liver
function.
Methods: This study was a retrospective chart review. A total of 138 patients with abnormal liver transaminase
levels at the time of admission were included in this study. We evaluated the influence of combined therapy of
conventional and herbal medicines on liver transaminase levels over a period of at least 2 weeks at Kyung Hee
University Korean Medical Hospital. Analyses were performed using SPSS version 17.0 for Windows. Paired T-tests
were used to examine the significance of differences in AST, ALT, and GGT levels at the time of admission and
discharge.
Results: We found that combined therapy reduced levels of aspartate aminotransferase (AST), alanine aminotransferase
(ALT), and gamma glutamyl transferase (GGT) to a statistically significant level. Specifically, there were 48, 66, 104 subjects
who exhibited abnormal AST, ALT and GGT levels at admission, which was reduced to 13, 37, and 64 subjects after
combined therapy, respectively. Some subjects exhibited worsening levels of liver transaminases after combined therapy,
so we used the χ2 test to analyze the influence of combined therapy with conventional and herbal medicines on liver
function according to initial liver transaminase levels. According to this analysis, ALT and GGT levels may be more
important than AST levels in estimating the influence of combined therapy on patients with abnormal liver transaminase
levels.
Conclusions: Based on this retrospective chart review, combined therapy of conventional and herbal medicines would
be considered relatively safe. Thus, if patients have abnormal ALT or GGT levels, caution should be taken when
suggesting combined therapy with conventional and herbal medicines.
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Background
The use of natural and herbal products for medical pur-
poses has increased in many countries over the past few
years. [1, 2] Some Asian countries, including Korea, even
consider these natural and herbal products as medicines
useful for preventing and treating various diseases.
Indeed, many patients taking conventional medicine for
diseases such as hypertension, diabetes, and hyperlipid-
emia also take herbal medicines.
As the interest in herbal medicines and supplements
increases more and more, it has become necessary to
verify the influence of herbal medicines on liver func-
tion. Specifically, concerns about hepatotoxicity caused
by herbal medicines have been raised in several papers,
but remains controversial. [3–6] Indeed, several other
studies [7–10] have reported that herbal medicines are
safe and, with respect to liver function, are more helpful
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than harmful. Given the growing prevalence of com-
bined therapies of conventional and herbal medicines, a
large-scale retrospective study was performed in
Germany. [8] The authors of that study reported that
50.6% of 1,450 inpatients took herbal medicines at the
same time as conventional Western medicine, of which
14 (0.97%) had drug-induced liver injury, although the
prognosis of these patients was fine. Similarly, a study
performed in Japan reported that only a small percent-
age of patients taking combined therapies of conven-
tional and herbal medicines experience drug-induced
liver injury due to herbal medicine. [9, 10]
A drawback of the studies described above is that they
were performed using patients with normal liver trans-
aminase levels, focusing only on hepatotoxicity. Thus,
the influence of combined therapy of conventional and
herbal medicines on liver function itself remains unclear.
To generate primary research with respect to evaluate
the safety of combined therapy of conventional and
herbal medicines on liver function, we selected hospital-
ized patients who had more than one abnormal value of
aspartate aminotransferase (AST), alanine aminotrans-
ferase (ALT), and gamma glutamyl transferase (GGT) at
the first examination. We then evaluated the influence
of combined therapy (>2 weeks) on changes in AST,
ALT and GGT levels.
Methods
Subjects
We analyzed patients who were hospitalized in Kyung
Hee University Korean Medical Hospital. All patients
were selected according to the following inclusion and
exclusion criteria.
Inclusion criteria
① Patients who took herbal medicine combined with
conventional medicine during hospitalization.
② Patients who had more than one abnormal value of
AST, ALT, and GGT at first lab finding. AST > 40 U/L,
ALT > 40 U/L, and/or GGT > 50 U/L.
Exclusion criteria
① Patients who were lost to follow-up for AST, ALT,
and GGT levels before discharge.
Data collection and analysis
The general characteristics of the study subjects, infor-
mation about medications, and AST, ALT, and GGT
levels at admission and discharge were collected from
charts and analyzed retrospectively. Categorical data are
presented as ‘number (N) (%)’ while continuous-type
data are presented as the ‘mean ± standard deviation
(SD)’. Analyses were performed using SPSS version 17.0
for Windows. Paired T-tests were used to examine the
significance of differences in AST, ALT, and GGT levels
at the time of admission and discharge. All differences
were considered significant at P < 0.05.
Ethical issues
This study was approved by the Institutional Review
Board of Kyung Hee University Korean Medical Hos-
pital. (IRB No. KOMCGIRB 2013-135)
Results
General characteristics of study subjects
The study consisted of a total of 138 subjects, 82 of them
were male and 56 were female. The mean age was 60.12 ±
14.72 years old. The average interval of liver function tests
was 41.87 ± 33.32 days. The most frequent disease for
admission was cerebrovascular disease (ex. cerebral
hemorrhage, cerebral infarction, subarachnoid hemorrhage,
etc.), followed by the musculo-skeletal disorder, the psychi-
atric disorder (ex. depression, insomnia, etc.), the peripheral
nerve palsy (ex, Bell’s palsy, paralytic strabismus, etc.), the
vertigo and other diseases (idiopathic sudden hearing loss,
stomach pain, post-herpetic neuralgia, and acute hepatitis).
The average number of comorbidities was 2.224. The most
frequent comorbidity is hypertension, followed by diabetes
mellitus, cardiovascular disorders, and hyperlipidemia.
Total 58 subjects had hypertension and thirty, twenty-two,
and fifteen subjects had these comorbidities respectively.
Thirty nine subjects had no comorbidity. The average num-
ber of conventional medicines being taken by each patient
was 6.25. The most frequently used conventional medicine
comprised anti-hypertension drugs: 126 of total 138 pa-
tients were being treated with anti-hypertension drugs (52
calcium channel blockers, 30 β-adrenergic blockers, 29
angiotensin II receptor antagonists, and 15 diuretics). The
second and the third frequently used conventional medi-
cine was anticoagulants & antithrombotics and agents for
the digestive system respectively, followed by antiepileptics
& skeletal muscle relaxants, agent for arteriosclerosis, anti-
depressants & tranquilizers, antidiabetics, and antiplatelet.
It is uncertain for most subjects to identify the cause of
liver biochemistry test abnormalities. Only twenty six sub-
jects had non-alcoholic fatty liver disease. Six subjects had
chronic hepatitis B and four subjects had alcoholic liver dis-
ease. One subject admitted to hospital for acute hepatitis.
Table 1 illustrated clinical characteristics, primary
diagnosis for admission, comorbidities, conventional
medicines that were taken and cause of liver biochemis-
try test abnormalities of all subjects.
Comparison of liver transaminase levels before and after
combined therapy with conventional and herbal medicines
The mean levels of AST, ALT, and GGT were signifi-
cantly decreased during hospitalization. Specifically, the
average AST level at admission and discharge was
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45.87 ± 49.68(U/L) and 27.64 ± 15.42 (U/L), respect-
ively. Likewise, the average ALT at admission and dis-
charge was 54.42 ± 69.87 (U/L) and 33.09 ± 24.29 (U/L),
while that of GGT was 97.89 ± 102.57 (U/L) and 63.46
± 52.34 (U/L), respectively (Table 2).
A total of 48 subjects had abnormal AST at admission
while 13 subjects showed abnormal AST after combined
therapy. Among the 13 subjects who presented with an
abnormal AST, 9 subjects showed higher levels and 4
subjects showed lower AST levels compared to admis-
sion after combined therapy. A total of 69 subjects had
abnormal ALT at admission and 37 subjects exhibited
abnormal ALT after combined therapy. Among the 37
subjects who presented with an abnormal ALT, 18 had a
higher ALT level while 19 subjects had a lower ALT
level after combined therapy. Lastly, 109 subjects had an
abnormal GGT at admission, 64 of which had an abnor-
mal GGT after combined therapy. Among the 64 sub-
jects who continued to have an abnormal GGT, 27
actually had a higher GGT level while 37 had a lower
GGT level after combined therapy compared to the time
of admission.
From a statistical standpoint, the average AST level at
admission was 81.29 ± 71.75 (U/L), which decreased to
34.71 ± 20.77 (U/L) after combined therapy, with a sig-
nificance probability less than 0.001. Likewise, the aver-
age of admission ALT was 87.85 ± 89.65 (U/L), which
decreased to 42.18 ± 25.27 (U/L) after combined therapy,
with a significance probability less than 0.001. Finally,
the average GGT level at admission was 119.33 ± 109.86
(U/L), which decreased to 72.72 ± 55.38 (U/L) after com-
bined therapy GGT, the significance of which was lower
than 0.001 (Table 2).
Considering the period of combined therapy with con-
ventional medicine and herbal medicine, the levels of
AST, ALT, and GGT in subjects belonging to the 2–4
week treatment group were significantly decreased (P =
0.003, P = 0.003, and P = 0.004, respectively). Likewise,
for the 4–8 weeks group, AST and GGT levels were de-
creased significantly (P = 0.025 and P = 0.011, respect-
ively), while the ALT level was not significantly changed.
(P = 0.070). Similar to the 4–8 week group, in subjects
who received combined therapy for more than 8 weeks,
the levels of AST and GGT were significantly decreased
(P = 0.013 and P = 0.001, respectively), while that of ALT
was not significantly changed (P = 0.110) (Table 3).
The influence on AST, ALT, and GGT change after
combined therapy with conventional and herbal medicine
Although above results of liver transaminase levels
showed safety of combined therapy, some subjects ex-
hibited worsening levels of liver transaminases after
combined therapy, so we next used the χ2 test to analyze
the influence of combined therapy with conventional
Table 1 clinical characteristics, primary diagnosis for admission,
comorbidities, conventional medicines that were taken and
cause of liver biochemistry test abnormalities
Item Number (%)
Number of patients 138 (100)
Gender Male 82 (59.42), Female 56 (40.58)
Age (mean ± SD) 60.12 ± 14.72
Days of liver function test interval 41.87 ± 33.32
Primary diagnosis
Cerebrovascular disease 82 (59.42)
Musculo-skeletal disorders 17 (12.31)
Psychiatric disorders 15 (10.86)
Peripheral nerve palsy 13 (9.42)
Vertigo 6 (4.34)
Other diseases 5 (3.65)
Comorbiditis
Average number of comorbiditis 2.224
Hypertension 58 (42.02)
Diabetes mellitus 30 (21.73)









Anticoagulants & Antithrombotics 122 (88.40)
Agent for digestive system 109 (78.98)
Antiepileptics & Skeletal muscle
relaxants
67 (48.55)
Agent for arteriosclerosis 66 (47.82)
Antidepressants & Tranquilizers 66 (47.82)
Antidiabetics 44 (31.88)
Antiplatelet 44 (31.88)
Other CNS drugs 39 (28.26)
Other circulatory agents 28 (20.28)
Agents for liver diseases 22 (15.94)
NSIDS 21 (15.21)
Others
Cause of liver biochemistry test
abnormalities
Acute Hepatitis 1 (0.72)
Chronic hepatitis B 6 (4.35)
Chronic hepatitis C 0 (0)
Alcoholic liver disease 4 (2.90)
Non-alcoholic fatty liver disease 26 (18.84)
Others 101 (73.19)
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and herbal medicines on liver function according to initial
liver transaminase levels. Considering the categorization of
the liver transaminases, the prevalence of abnormal ALT
and GGT after the combined therapy with conventional
and herbal medicines in the abnormal group at baseline
was 6.55 and 4.02 times higher than in normal range group
at baseline, respectively. (P = 0.000 and P = 0.002, respect-
ively) (Table 4).
Discussion
A growing number of people are taking conventional medi-
cines for the treatment of diseases like hypertension, hyper-
lipidemia, and diabetes, which has coincided with an
increase in the use of herbal medicines. [1, 2] Therefore for
safe use of combined therapy with conventional and herbal
medicines, it is necessary to study the influence of combine
therapy on patients, especially with respect to the liver.
Several previous Korean studies have analyzed the influ-
ence of herbal medicine or combined therapy with
conventional and herbal medicines on liver function,
reporting that herbal medicines can be considered safe for
liver function.[11–13] Two other studies [11, 12] were
performed using admitted patients similar to the present
study; however, they did not distinguish between patients
with normal and abnormal liver transaminase levels.
Indeed, most of the study subjects in the aforementioned
studies had normal liver transaminases, and no effort
made to separate patients who took herbal medicines
from those who took combined therapy. A cross-sectional
study by Park et al [13] evaluated herbal medicine intake
and abnormal liver function. In that study abnormal liver
function was not related with history of herbal medicine
intake, but was related with male sex and overweight
status. Specifically, among a total of 497 patients, 49 had
not taken any medicine, 219 patients had taken only con-
ventional medicine, 72 patients had taken only herbal
medicine, and 157 patients had taken combined therapy.
However, the authors of that study compared only two
groups as follows: 219 patients who had taken only con-
ventional medicine and 72 patients who had taken only
herbal medicine.
Patients with underlying liver disease have a higher
morbidity of liver injury caused by medicines compared
with healthy individuals. [14] We assumed that if com-
bined therapy with conventional and herbal medicine is
harmful for liver function, patients with abnormal liver
transaminase levels could be sensitive to combined ther-
apy. Therefore, we focused on admitted patients at our
hospital with abnormal liver transaminase levels to more
clearly study the influence of combined therapy on liver
Table 2 Comparison of AST, ALT and GGT levels of all subjects and each subject group with abnormal liver transaminase levels
before and after combined therapy with conventional and herbal medicines





AST, ALT and GGT levels among all subjects AST(U/L) 138 45.87 ± 49.68 27.64 ± 15.42 <0.001*
ALT(U/L) 138 54.42 ± 69.87 33.09 ± 24.29 <0.001*
GGT(U/L) 138 97.89 ± 102.57 63.46 ± 52.34 <0.001*
AST, ALT and GGT of each subject group with abnormal liver transaminase levels AST(U/L) 48 81.29 ± 71.75 34.71 ± 20.77 <0.001*
ALT(U/L) 66 87.85 ± 89.65 42.18 ± 25.27 <0.001*
GGT(U/L) 104 119.33 ± 109.86 72.72 ± 55.38 <0.001*
*Analyzed by paired T-test, significant: P < 0.05
Table 3 Comparison of AST, ALT, and GGT of subjects according to the length of combined therapy with conventional and herbal
medicines





2-4 weeks 58 AST(U/L) 47.55 ± 56.49 28.72 ± 18.29 0.003*
ALT(U/L) 64.86 ± 79.30 36.29 ± 26.64 0.003*
GGT(U/L) 101.79 ± 117.43 68.22 ± 54.09 0.004*
4-8 weeks 52 AST(U/L) 39.62 ± 31.30 28.96 ± 14.19 0.025*
ALT(U/L) 41.83 ± 24.62 34.00 ± 25.60 0.070
GGT(U/L) 93.23 ± 104.11 65.38 ± 53.90 0.011*
More than 8 weeks 28 AST(U/L) 54.00 ± 61.53 22.96 ± 9.57 0.013*
ALT(U/L) 56.18 ± 99.01 24.79 ± 12.76 0.110
GGT(U/L) 98.46 ± 61.04 50.04 ± 44.64 0.001*
*Analyzed by paired T-test, significant: P < 0.05
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function. Conventional medicines, especially those for
hypertension, hyperlipidemia, and diabetes mellitus, are
typically taken long-term. Likewise, herbal medicines are
typically taken long-term rather than short-term because
their effect is slow to manifest. Thus, we limited our
analysis to patients who had taken combined therapy
longer than 2 weeks.
This study didn’t attempt to confirm the efficacy of
combined therapy but to evaluate the influence of com-
bined therapy on liver function. Usually we clinicians
couldn’t check every single medicine that has taken by
patients, whether it is conventional or herbal. Therefore
we roughly checked conventional and herbal medicines.
Herbal medicines are usually composed of several
different types of herbs. Thus, we also documented the
specific herbs being taken by patients. A total of 202
different kinds of herbs were used among the 138 en-
rolled patients. The most frequently used herbs were
Rhemannia glutinosa (Gaertner) Liboschitz and Gly-
cyrrhiza uralensis Fisch, which were used by all 138
patients. In addition, there were seven herbs used by greater
than 100 patients: Poria cocos (Schw.) Wolf, Panax ginseng
C. A. Mey. (= Panax schinseng Nees), Atractylodes macro-
cepha-la Koidz, Angelica gigas Nakai, Scutellaria baicalen-
sis Georgi, Paeonia albiflora Pallas var. trichocarpa Bunge,
and Zingiber officinale Rosc. Finally, 90 of the 202 different
herbs were used by less than 10 patients, and only 26 herbs
were used by more than half of patients.
There are several herbs which were considered harmful
for liver function. In Korea, Yun et al [7] and Park et al
[15] reported that there some herbs, for example Ephedra
sinica Stapf, Scutellaria baicalensis Georgi, Dictamnus
dasycarpus Turcz., Aconitum carmichaeli Debx (= Aconi-
tum chinense Sieb. et Zucc.), Euphorbia kansui Liou ex
Wang, Croton tiglium Linne, Pinellia ternata (Thunb.)
Breit., Rheum palmatum L., Sinomenium acutum Rehder
et Wils., Polygonum multiflorum Thunb.,Valeriana fauriei
Briquet could be harmful for liver function. F. Stickel & D.
Shouval [3], C. Korth [4], and E.S. Bjornsson [16] also re-
ported about the herbs which could be potentially harmful
for liver function. Some of the herbs in these studies, for
example Agastache rugosa (Fisch. et Meyer) O. Kuntze,
Tussilago farfara L. [3], Chelidonium majus L., Cimicifuga
heracleifolia Kom. [4], Plantago asiatica L. [16] were used
but the other herbs were not used for the subjects in this
study.
Table 5 illustrated the herbs which could be harmful
for liver function were used in this study.
The present study represents a primary research study
on the safety of combined therapy with respect to liver
function. Despite the positive finding that the average
AST, ALT, and GGT levels of the 138 subjects were sig-
nificantly reduced, there were a few subjects who had
abnormal liver transaminase levels after combined ther-
apy. Thus, in order to confirm the main factors by which
liver transaminases predict the influence of combined
therapy on liver function, which will be useful for
Table 4 The influence on AST, ALT and GGT change following combined therapy with conventional and herbal medicines
After the combined therapy with conventional and herbal medicines N (%)
Before the combined therapy with conventional and herbal
medicines N (%)
Normal range Abnormal range P-value
AST Normal range 85 (61.6%) 6 (4.3%) 0.132
Abnormal range 40 (29.0%) 7 (5.1%)
ALT Normal range 65 (47.1%) 8 (5.8%) 0.000*
Abnormal range 36 (26.1%) 29 (21.1%)
GGT Normal range 27 (19.6%) 8 (5.8%) 0.002*
Abnormal range 47 (34.1%) 56 (40.6%)
*Analyzed by χ2 test, significant: P < 0.05
Table 5 The number of cases prescribed herbs previously
reported as hepatotoxic agents
Herbs Commonly used for Number of
cases
Glycyrrhiza uralensis Fisch. Essential herbs for
herbal medicine
138
Scutellaria baicalensis Georgi Fever 104
Pinellia ternata (Thunb.) Breit. Vertigo, Nausea 84
Rheum palmatum L. Constipation 60
Cimicifuga heracleifolia Kom. Menopausal syndrome 52
Coptis deltoidea C.Y. Cheng
et Hsiao
Fever 48
Ephedra sinica Stapf. Edema, Obesity 39





Plantago asiatica L. Constipation 30
Aconitum carmichaeli Debx Heart stimulant 19
Aconitum ciliare DC. Blood circulation 7




Corydalis ternata Nakai For extravasated blood 6
Polygonum multiflorum Thunb. Adaptogen 4
Chelidonium majus L. Fever 1
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clinicians who are considering suggesting combined
therapy with conventional and herbal medicines, we ana-
lyzed subjects with abnormal liver transaminases using
the χ2 test. According to this analysis, ALT and GGT
levels may be more important than AST levels in esti-
mating the influence of combined therapy on patients
with abnormal liver transaminase levels. Thus, if patients
have abnormal ALT or GGT levels, caution should be
taken when suggesting combined therapy with conven-
tional and herbal medicines.
This study had some weak points. First, the subjects in
this study consisted of individuals who were admitted to
the hospital, and thus were able to eat a healthy diet, did
not consume alcoholic drinks, and were able to rest.
Under such circumstances it is likely that the liver may
be better able to repair itself. Therefore, future studies
should be conducted in an outpatient setting. Secondly,
unlike conventional medicines, herbal medicines consist
of natural herbs, which can vary significantly with
respect to quality. Thus, herbal medicines made with
cheap herbs contaminated by agricultural chemicals or
heavy metals may be harmful to liver compared with
products of a higher quality. Thirdly, this study was a
primary retrospective research study. In order to more
fully evaluate the influence of combine therapy on liver
function, it will be necessary to perform a randomized
control study. Finally, this finding is a short term obser-
vation and that data regarding long term outcomes
would be necessary to reach more definitive conclusions.
Conclusions
The results of this retrospective study suggest that com-
bined therapy with conventional and herbal medicines is
relatively safe on liver function. However, some patients
had increased liver transaminase levels, highlighting the
importance of routine lab examination to continuously
monitor patients with abnormal liver transaminase levels.
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